A robust potency assay highlights significant donor variation of human mesenchymal stem/progenitor cell immune modulatory capacity and extended radio-resistance

The inherent immunomodulatory capacity of mesenchymal stem/progenitor cells (MSPCs) encouraged initiation of multiple clinical trials. Release criteria for therapeutic MSPCs cover identity, purity and safety but appropriate potency assessment is often missing. Reports on functional heterogeneity of...

Descripción completa

Detalles Bibliográficos
Autores principales: Ketterl, Nina, Brachtl, Gabriele, Schuh, Cornelia, Bieback, Karen, Schallmoser, Katharina, Reinisch, Andreas, Strunk, Dirk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Method
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4666276/
https://www.ncbi.nlm.nih.gov/pubmed/26620155
http://dx.doi.org/10.1186/s13287-015-0233-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4666276/
https://www.ncbi.nlm.nih.gov/pubmed/26620155
http://dx.doi.org/10.1186/s13287-015-0233-8

Ejemplares similares